Skip to content

Addiction: all studies

Page 363 of 863: studies 3,621 to 3,630 of 8,627, newest first. Back to the addiction overview

Research

Finnegans is the Tolstoy of the Uitoto

Mundo Amazónico April 4, 2024 Jimmy Weiskopf

The Word, as the creative principle of life, is a concept found in many cultures, from the Hebraic to the Uitotos (or Murui) of the Colombian Amazon. The author finds parallels between the immersion of Joyce´s Finnegans Wake in the Word as the key to unlocking different but interrelated dimensions of reality, and the cosmo-vision of the Murui. Finnegans Wake presents a panoptic view of...

DOI: 10.15446/ma.v15n1.105208 (opens in new tab) Full text (opens in new tab) Finnegans wake Murui Amazonian cosmovisions Medicine plants +2

A multisite feasibility randomized clinical trial of mindfulness-based resilience training for aggression, stress, and health in law enforcement officers.

BMC Complementary Medicine and Therapies April 4, 2024 Michael Christopher, Sarah Bowen, Katie Witkiewitz et al. 9 citations

Law enforcement officers (LEOs) are exposed to significant stressors that can impact their mental health, increasing risk of posttraumatic stress disorder, burnout, at-risk alcohol use, depression, and suicidality. Compromised LEO health can subsequently lead to aggression and excessive use of force. Mindfulness training is a promising approach for high-stress populations and has been shown to...

The emergence of identity, agency and consciousness from the temporal dynamics of neural elaboration.

Frontiers in Network Physiology April 2, 2024 Riccardo Fesce

Identity—differentiating self from external reality—and agency—being the author of one’s acts—are generally considered intrinsic properties of awareness and looked at as mental constructs generated by consciousness. Here a different view is proposed. All physiological systems display complex time-dependent regulations to adapt or anticipate external changes. To interact with rapid changes, an...

DOI: 10.3389/fnetp.2024.1292388 (opens in new tab) Full text (opens in new tab) Consciousness Identity Agency Emergent properties +2

Are first responders interested in psychedelics? Assessing previous use, interest, and willingness to participate in psychedelic-assisted therapy

Journal of Psychedelic Studies April 2, 2024 Sonia M. Brodie, Chelsea Stunden, Jay A. Olson et al.

AbstractBackground and aimsFirst responders such as firefighters and police officers often experience traumatic events as part of their work. As a result, they are more likely to have mental health issues such as post-traumatic stress disorder, depression, and anxiety compared to the general population. Psychedelic-assisted therapy has emerged as a promising avenue to alleviate these issues,...

Global Versus Local Theories of Consciousness and the Consciousness Assessment Issue in Brain Organoids

Neuroethics April 1, 2024 Maxence Gaillard

AbstractAny attempt at consciousness assessment in organoids requires careful consideration of the theory of consciousness that researchers will rely on when performing this task. In cognitive neuroscience and the clinic, there are tools and theories used to detect and measure consciousness, typically in human beings, but none of them is neither fully consensual nor fit for the biological...

Increased emergency room visits without corresponding rehospitalizations in cannabis users with psychosis

European Psychiatry April 1, 2024 O. Martin-Santiago, M. Calvo-Valcarcel, P. Martinez.Gimeno et al.

Introduction Epidemiological studies have established a complex relationship between cannabis consumption and a heightened risk of psychotic disorders, including schizophrenia. However, this connection is multifaceted, influenced by genetics, environment, and individual psychology. Surprisingly, despite a surge in emergency room (ER) visits associated with cannabis consumption and psychosis,...

Cannabis use in first episode psychosis in Tunisia

European Psychiatry April 1, 2024 E. Bergaoui, R. Lansari, O. Chehaider et al.

IntroductionThe use of cannabis is associated with developing psychotic disorders, especially for those with a pre-existing vulnerability and elevated familial risk for psychosis.ObjectivesTo assess cannabis use during first episode psychosis and its relationship with patients’ clinical symptoms and functioning.MethodsWe assessed 50 patients hospitalized for first episode psychosis using three...

Navigating the “Psychedelic Renaissance”: From Research to Reality

International Journal of Mental Health and Addiction April 1, 2024 Doris Payer, Sukhpreet Klaire, Dominique Morisano et al. 4 citations

The field of psychedelics is in an important era, with a significant focus on the potential role of psychedelic compounds in the treatment of mental health and substance use disorders. In 2022, a scientific research conference was held in Toronto to bring together stakeholders from a variety of disciplines and to promote dialogue and collaboration. This Special Issue includes 8 papers based on...

The novel psychoactive substance 25E-NBOMe induces reward-related behaviors via dopamine D1 receptor signaling in male rodents

Archives of Pharmacal Research April 1, 2024 Young-Jung Kim, Wun-A Kook, Shi-Xun Ma et al. 3 citations

Novel psychoactive substances (NPSs) are new psychotropic drugs designed to evade substance regulatory policies. 25E-NBOMe (2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine) has recently been identified as an NPS, and its recreational misuse has been reported to be rapidly increasing. However, the psychopharmacological effects and mechanisms of 25E-NBOMe have not been studied. We...

DOI: 10.1007/s12272-024-01491-4 (opens in new tab) Full text (opens in new tab) 25e-nbome Novel psychoactive substance Reward Dopamine d1 receptor +1

Far Out: The Extended Denial of Public Access to Psychedelic Therapeutics

Texas A&M Journal of Property Law April 1, 2024 Andrew R. Waldeck

The United States patent regime is designed to promote dissemination of information that undergirds a particular innovation. To incentivize disclosure, inventors are granted a time-limited right to exclude others from practicing the invention, thereby affording the inventor a period in which to commercialize and financially benefit from their inventive contribution. The disclosure provides...

DOI: 10.37419/jpl.v10.i2.8 (opens in new tab) Denial Legislation Intellectual property Invention +2